Safety and efficacy of lenvatinib in Child-Pugh A and B patients with unresectable hepatocellular carcinoma in clinical practice

被引:0
|
作者
Ogushi, Katsuaki [1 ]
Chuma, Makoto [1 ]
Numata, Kazushi [1 ]
Uojima, Haruki [2 ]
Hidaka, Hisash [2 ]
Nakazawa, Takashi [2 ]
Hirose, Shunji [3 ]
Kagawa, Tatehiro [3 ]
Matsunaga, Koutarou [4 ]
Hattori, Nobuhiro [4 ]
Kobayashi, Satoshi [5 ]
Morimoto, Manabu [5 ]
Fukushima, Taito [5 ]
Iwabuchi, Shogo [6 ]
Fujikawa, Tomoaki [6 ]
Kako, Makoto [7 ]
Tanaka, Katsuaki [8 ]
Maeda, Shin [9 ]
机构
[1] Yokohama City Univ, Med Ctr, Gastroenterol, Yokohama, Kanagawa, Japan
[2] Kitasato Univ Hosp, Gastroenterol, Sagamihara, Kanagawa, Japan
[3] Tokai Univ Hosp, Gastroenterol, Isehara, Kanagawa, Japan
[4] St Marianna Univ, Sch Med Hosp, Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan
[5] Kanagawa Canc Ctr, Gastroenterol, Yokohama, Kanagawa, Japan
[6] Shonan Fujisawa Tokushukai Hosp, Gastroenterol, Fujisawa, Kanagawa, Japan
[7] Shonan Kamakura Gen Hosp, Gastroenterol, Kamakura, Kanagawa, Japan
[8] Japanese Red Cross Hadano Hosp, Gastroenterol, Hadano, Japan
[9] Yokohama City Univ Med, Yokohama, Kanagawa, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT495
引用
收藏
页码:S901 / S903
页数:3
相关论文
共 50 条
  • [21] Sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (HCC): Safety and efficacy in Child-Pugh (CP) class A and B patients
    Pressiani, Tiziana
    Boni, Corrado
    Rimassa, Lorenza
    Labianca, Roberto
    Fagiuoli, Stefano
    Ardizzoni, Andrea
    Foa, Paolo
    Cortesi, Enrico
    Giordano, Laura
    Santoro, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [22] Liver transplantation for advanced hepatocellular carcinoma in patients with Child-Pugh A and B
    Ahmed Hammad
    Toshimi Kaido
    Kohei Ogawa
    Yasuhiro Fujimoto
    Tadahiro Uemura
    Akira Mori
    Etsuro Hatano
    Hideaki Okajima
    Shinji Uemoto
    Surgery Today, 2016, 46 : 248 - 254
  • [23] Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma
    Silvia Camera
    Margherita Rimini
    Federico Rossari
    Toshifumi Tada
    Goki Suda
    Shigeo Shimose
    Masatoshi Kudo
    Changhoon Yoo
    Jaekyung Cheon
    Fabian Finkelmeier
    Ho Yeong Lim
    José Presa
    Gianluca Masi
    Francesca Bergamo
    Francesca Salani
    Mariarosaria Marseglia
    Elisabeth Amadeo
    Francesco Vitiello
    Takashi Kumada
    Naoya Sakamoto
    Hideki Iwamoto
    Tomoko Aoki
    Hong Jae Chon
    Vera Himmelsbach
    Massimo Iavarone
    Giuseppe Cabibbo
    Margarida Montes
    Francesco Giuseppe Foschi
    Caterina Vivaldi
    Sara Lonardi
    Takuya Sho
    Takashi Niizeki
    Naoshi Nishida
    Christoph Steup
    Masashi Hirooka
    Kazuya Kariyama
    Joji Tani
    Masanori Atsukawa
    Koichi Takaguchi
    Ei Itobayashi
    Shinya Fukunishi
    Kunihiko Tsuji
    Toru Ishikawa
    Kazuto Tajiri
    Hironori Ochi
    Satoshi Yasuda
    Hidenori Toyoda
    Chikara Ogawa
    Takashi Nishimura
    Takeshi Hatanaka
    Targeted Oncology, 2024, 19 : 29 - 39
  • [24] Nivolumab for Child-Pugh B advanced hepatocellular carcinoma
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (08): : 614 - 614
  • [25] Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma
    Camera, Silvia
    Rimini, Margherita
    Rossari, Federico
    Tada, Toshifumi
    Suda, Goki
    Shimose, Shigeo
    Kudo, Masatoshi
    Yoo, Changhoon
    Cheon, Jaekyung
    Finkelmeier, Fabian
    Lim, Ho Yeong
    Presa, Jose
    Masi, Gianluca
    Bergamo, Francesca
    Salani, Francesca
    Marseglia, Mariarosaria
    Amadeo, Elisabeth
    Vitiello, Francesco
    Kumada, Takashi
    Sakamoto, Naoya
    Iwamoto, Hideki
    Aoki, Tomoko
    Chon, Hong Jae
    Himmelsbach, Vera
    Iavarone, Massimo
    Cabibbo, Giuseppe
    Montes, Margarida
    Foschi, Francesco Giuseppe
    Vivaldi, Caterina
    Lonardi, Sara
    Sho, Takuya
    Niizeki, Takashi
    Nishida, Naoshi
    Steup, Christoph
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Hatanaka, Takeshi
    TARGETED ONCOLOGY, 2024, 19 (1) : 29 - 39
  • [26] Efficacy and Safety of Lenvatinib for Unresectable Hepatocellular Carcinoma in Patients with Baseline Hepatitis B Virus (HBV)
    Han, Kwang-Hyub
    Qin, Shukui
    Piscaglia, Fabio
    Park, Joong-Won
    Komov, Dimitry
    Ryoo, Baek-Yeol
    OuYang, Xuenong
    Yoon, Jung-Hwan
    Tak, Won Young
    Ren, Min
    Stepan, Daniel
    Tamai, Toshiyuki
    Dutcus, Corina E.
    Cheng, Ann-Lii
    HEPATOLOGY, 2017, 66 : 740A - 741A
  • [27] Outcomes After Stereotactic Body Radiation for Hepatocellular Carcinoma in Patients With Child-Pugh A Versus Child-Pugh B/C Cirrhosis
    Diamond, Brett H.
    Banson, Kara
    Ayash, Jonathan
    Lee, Peter
    Shukla, Utkarsh C.
    Jones, Gavin
    Rava, Paul
    Fitzgerald, Thomas J.
    Sioshansi, Shirin
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (12)
  • [28] Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients
    Rimini, Margherita
    Persano, Mara
    Tada, Toshifumi
    Suda, Goki
    Shimose, Shigeo
    Kudo, Masatoshi
    Cheon, Jaekyung
    Finkelmeier, Fabian
    Lim, Ho Yeong
    Presa, Jose
    Salani, Francesca
    Lonardi, Sara
    Piscaglia, Fabio
    Kumada, Takashi
    Sakamoto, Naoya
    Iwamoto, Hideki
    Aoki, Tomoko
    Chon, Hong Jae
    Himmelsbach, Vera
    Schirripa, Marta
    Montes, Margarida
    Vivaldi, Caterina
    Solda, Caterina
    Hiraoka, Atsushi
    Sho, Takuya
    Niizeki, Takashi
    Nishida, Naoshi
    Steup, Christoph
    Hirooka, Masashi
    Kariyama, Kazuya
    Tani, Joji
    Atsukawa, Masanori
    Takaguchi, Koichi
    Itobayashi, Ei
    Fukunishi, Shinya
    Tsuji, Kunihiko
    Ishikawa, Toru
    Tajiri, Kazuto
    Ochi, Hironori
    Yasuda, Satoshi
    Toyoda, Hidenori
    Ogawa, Chikara
    Nishimura, Takashi
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Shimada, Noritomo
    Kawata, Kazuhito
    Tada, Fujimasa
    Ohama, Hideko
    Nouso, Kazuhiro
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7565 - 7577
  • [29] Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients
    Margherita Rimini
    Mara Persano
    Toshifumi Tada
    Goki Suda
    Shigeo Shimose
    Masatoshi Kudo
    Jaekyung Cheon
    Fabian Finkelmeier
    Ho Yeong Lim
    José Presa
    Francesca Salani
    Sara Lonardi
    Fabio Piscaglia
    Takashi Kumada
    Naoya Sakamoto
    Hideki Iwamoto
    Tomoko Aoki
    Hong Jae Chon
    Vera Himmelsbach
    Marta Schirripa
    Margarida Montes
    Caterina Vivaldi
    Caterina Soldà
    Atsushi Hiraoka
    Takuya Sho
    Takashi Niizeki
    Naoshi Nishida
    Christoph Steup
    Masashi Hirooka
    Kazuya Kariyama
    Joji Tani
    Masanori Atsukawa
    Koichi Takaguchi
    Ei Itobayashi
    Shinya Fukunishi
    Kunihiko Tsuji
    Toru Ishikawa
    Kazuto Tajiri
    Hironori Ochi
    Satoshi Yasuda
    Hidenori Toyoda
    Chikara Ogawa
    Takashi Nishimura
    Takeshi Hatanaka
    Satoru Kakizaki
    Noritomo Shimada
    Kazuhito Kawata
    Fujimasa Tada
    Hideko Ohama
    Kazuhiro Nouso
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7565 - 7577
  • [30] Systematic review and meta-analysis of safety and efficacy of atezolizumab/ bevacizumab in Child-Pugh class B patients with hepatocellular carcinoma
    Pasta, A.
    Calabrese, F.
    Jaffe, A.
    Labanca, S.
    Marenco, S.
    Pieri, G.
    Torres, M. C. Plaz
    Strazzabosco, M.
    Giannini, E. G.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S221 - S221